ACGL posts strong premium growth and expands globally but faces geopolitical risks and weaker returns on invested capital.
Zacks.com users have recently been watching Arch Capital (ACGL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ACGL tops Q2 estimates as premiums and investment income rise, lifting revenues nearly 21% year over year.
Arch Capital Group Ltd. (NASDAQ:ACGL ) Q2 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Francois Morin - Executive VP, CFO & Treasurer Nicolas Alain Emmanuel Papadopoulo - CEO & Director Conference Call Participants Andrew E.
The headline numbers for Arch Capital (ACGL) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Arch Capital Group (ACGL) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.57 per share a year ago.
Arch Capital launches a flexible supplemental health suite aimed at gig workers and independents to boost growth and diversify revenues.
ACGL's Q2 results are likely to reflect rate increases, new business opportunities, growth in invested asset base, and improved pricing.
Arch Capital Group (ACGL) concluded the recent trading session at $89, signifying a +1.66% move from its prior day's close.
Arch Capital (ACGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arch Capital Group (ACGL) closed the most recent trading day at $88.19, moving 2.65% from the previous trading session.
The latest trading day saw Arch Capital Group (ACGL) settling at $87.92, representing a -2.54% change from its previous close.